Similarly, a promoter hypermethylation of G-protein signaling 2 (RGS2) gene by UHRF1 resulted in gene suppression and enhanced carcinogenesis in bladder cancer [46]. This evidence concerns the gene UHRF1 and urinary bladder carcinoma.